Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

BREAKING NEWS
Source: Thailand Medical News  May 17, 2019  4 years, 11 months, 2 days, 56 minutes ago

Metformin Emerging as New Treatment for Fibromyalgia As Study Links Insulin Resistance As The Cause

Metformin Emerging as New Treatment for Fibromyalgia As Study Links Insulin Resistance As The Cause
Source: Thailand Medical News  May 17, 2019  4 years, 11 months, 2 days, 56 minutes ago
Fibromyalgia is one of the most common existing conditions causing chronic pain and disability. The economic impact of fibromyalgia worldwide is phenomenal -- in the U.S. alone, related health care costs linked to this condition is about $100 billion annually. Despite extensive research the cause of fibromyalgia is unknown, hence there is no specific diagnostics or therapies for this condition other than pain-reducing drugs including controversial opioids in certain cases.


 

However, researchers from The University of Texas Medical Branch at Galveston were recently able to demonstrate the correlation between insulin resistance and fibromyalgia. They dramatically reduced the pain of fibromyalgia patients with medications that targeted insulin resistance. Metformin was the preferred drug in the study.
 
“This discovery could drastically alter the way that chronic pain can be identified and managed.” Dr. Miguel Pappolla, UTMB professor of neurology in an exclusive interview with Thailand Medical News. “It may lead to a revolutionary change on how fibromyalgia and related forms of chronic pain are treated. The new approach has the potential to save billions of dollars to the health care system and decrease many peoples' dependence on opiates for pain management.”
 
The UTMB team of researchers, along with collaborators from across the U.S., were able for the first time, t separate patients with fibromyalgia from normal individuals using a common blood test for insulin resistance, or pre-diabetes. They then treated the fibromyalgia patients with a medication  targeting insulin resistance, in this case metformin was used. This dramatically reduced their pain levels of patients in the study.
 
“Studies in the past indicated that insulin resistance causes dysfunction within the brain's small blood vessels. Since this issue is also present in fibromyalgia, we studied whether insulin resistance is the missing link or component  in this disorder," Pappolla said. "We discovered that most patients with fibromyalgia can be identified by their A1c levels, which reflects average blood sugar levels over the past two to three months."
 
It was discovered in the study that pre-diabetics with slightly elevated A1c values carry a higher risk of developing central (brain) pain, a key feature of fibromyalgia and other chronic pain disorders."
 
The researchers identified patients who were referred to a subspecialty pain medicine clinic to be treated for widespread muscular/connective tissue pain. All patients who met the criteria for fibromyalgia were separated into smaller groups